Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.362.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.362.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.362.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.362.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.362.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.362.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.48EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.48ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.48ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.48EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.48EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.520EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.520EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.520ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.520ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.520EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.520EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.520ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.520ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.38ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.38ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.38EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.38EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.23EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.30ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.30ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used